| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16K | -5.9% | -44.8% |
| Cost of Revenue | $41K | +0.0% | +215.4% |
| R&D Expense | $3.3M | -1.6% | -6.2% |
| SG&A Expense | $4.1M | -1.4% | -2.8% |
| Operating Income | -$9.0M | +3.6% | -1.3% |
| Interest Expense | $2K | +0.0% | -60.0% |
| Net Income | -$7.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.1M | -18.6% | +52.0% |
| Short-term Investments | $39.2M | +11.6% | -16.7% |
| Accounts Receivable | $14K | -17.6% | -82.3% |
| Current Assets | $44.5M | +8.9% | -12.9% |
| Total Assets | $108.1M | -3.3% | +36.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.5M | — | — |
| Capital Expenditures | $396K | — | — |
| Investing Cash Flow | -$34.4M | — | — |
| Financing Cash Flow | $53.9M | — | — |
| Free Cash Flow | -$19.9M | — | — |
| +2.9% |
| +1.3% |
| EPS (Basic) | -$0.16 | +0.0% | +33.3% |
| EPS (Diluted) | -$0.16 | +0.0% | +33.3% |
| $23.5M |
| -0.4% |
| -2.8% |
| Total Liabilities | $25.9M | +9.9% | +6.5% |
| Stockholders' Equity | $82.2M | -6.9% | +50.4% |